XML 47 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities
3 Months Ended
Apr. 30, 2014
Notes to Financial Statements  
Derivative Liabilities

Note 10 – Derivative Liabilities:

 

Derivative warrant liability

The Company has warrants outstanding with price protection provisions that allow for the reduction in the exercise price of the warrants in the event the Company subsequently issues stock or securities convertible into stock at a price lower than the exercise price of the warrants. Simultaneously with any reduction to the exercise price, the number of shares of common stock that may be purchased upon exercise of each of these warrants shall be increased or decreased proportionately, so that after such adjustment the aggregate exercise price payable for the adjusted number of warrants shall be the same as the aggregate exercise price in effect immediately prior to such adjustment.

 

Accounting for Derivative Warrant Liability

The Company’s derivative instruments have been measured at fair value at April 30, 2014 and July 31, 2013 using the binomial lattice model. The Company recognizes all of its warrants with price protection in its consolidated balance sheets as a liability. The liability is revalued at each reporting period and changes in fair value are recognized currently in the consolidated statements of operations. The initial recognition and subsequent changes in fair value of the derivative warrant liability have no effect on the Company’s consolidated cash flows.

 

The derivative warrants outstanding at April 30, 2014 are all currently exercisable with a weighted-average remaining life of 3.6 years.

 

The revaluation of the warrants at the end of the respective reporting periods resulted in the recognition of a gain of $298,370 within the Company’s consolidated statements of operations for the nine months ended April 30, 2014 and a loss of $1,092,504 within the Company’s consolidated statements of operations for the nine months ended April 30, 2013, which is included in the consolidated statement of operations under the caption “Change in fair value of derivative liabilities”. The fair value of the warrants at April 30, 2014 and July 31, 2013 was $5,699,770 and $5,234,293, respectively, which is reported on the consolidated balance sheets under the caption “Derivative Warrant Liability”. The following summarizes the changes in the value of the derivative warrant liability from August 1, 2012 until April 30, 2014:

              Value No. of Warrants
Balance at August 1, 2012 – Derivative warrant liability $   4,081,627 55,148,530
Additional warrants issued in August 2012 financing   624,797   9,375,000
Additional warrants issued in December 2012 financing   762,355 24,999,999
Additional warrants issued in June 2013 financing   1,189,744  40,833,335
Additional warrants from price protection features of existing warrants   7,484,550   236,219,094
Exercise of warrants (5,629,130) (145,888,421)
Decrease in fair value of derivative warrant liability (3,279,650)                   n/a
Balance at July 31, 2013 – Derivative warrant liability  $   5,234,293   220,687,537
Exercise of warrants (2,194,496) (76,732,020)
Additional warrants issued in January 2014 financing   942,279 26,666,668
Additional warrants issued in March 2014 financing   2,016,064 69,166,667
Decrease in fair value of derivative warrant liability    (298,370)                  n/a
Balance at April 30, 2014 – Derivative warrant liability  $  5,699,770   239,788,852

 

Fair Value Assumptions Used in Accounting for Derivative Warrant Liability

The Company has determined its derivative warrant liability to be a Level 2 fair value measurement and has used the binominal lattice pricing model to calculate the fair value as of April 30, 2014 and July 31, 2013. The binomial lattice model requires six basic data inputs: the exercise or strike price, time to expiration, the risk free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Because the warrants contain the price protection feature, the probability that the exercise price of the warrants would decrease as the stock price decreased was incorporated into the valuation calculations. The key inputs used in the April 30, 2014 and July 31, 2013 fair value calculations were as follows:

    April 30, 2014     July 31, 2013  
Current exercise price   $ 0.03     $ 0.03  
Time to expiration     3.6 years       3.5 years  
Risk-free interest rate     0.91 %     0.49 %
Estimated volatility     82 %     85 %
Dividend     -0-       -0-  
Stock price at period end date   $ 0.035     $ 0.035  

 

Fair Value Assumptions Used in Accounting for Derivative Additional Investment Rights Liability

The Company has determined the derivative additional investment rights liability to be a Level 2 fair value measurement and has used the binominal lattice pricing model to measure the fair value. The fair value of the derivative liability associated with the additional investment rights was determined to be $819,882 and $1,256,160 at April 30, 2014 and July 31, 2013, respectively. There were no additional investment rights at April 30, 2013.

 

The key inputs used in the fair value calculation at April 30, 2014 and July 31, 2013 were as follows:

 

    April 30, 2014     July 31, 2013  
Underlying number of units of convertible preferred stock     2,500       1,225  
Underlying number of units of warrants     83,333,334       40,833,335  
Current exercise price of warrants   $ 0.03     $ 0.03  
Current conversion price of preferred stock   $ 0.03     $ 0.03  
Time to expiration     0.78 years       0.88 years  
Risk-free interest rate     0.10 %     0.11 %
Estimated volatility     52 %     114 %
Dividend     -0-       -0-  
Stock price at period end date   $ 0.035     $ 0.035  

 

The partial exercise of the additional investment rights in the quarter ended January 31, 2014, resulted in a transfer from the derivative liability to additional paid in capital of $237,566, which was the estimated fair value of the additional investment rights exercised as of the date of exercise on January 15, 2014. The revaluation of the additional investment rights in the nine-month period ended April 30, 2014, resulted in the recognition of a gain of $1,062,448 within the Company’s consolidated statements of operations, which is included in the total under the caption “Change in fair value of derivative liabilities”.